Overview
Squamous cell carcinoma of the head and neck (SCCHN) is a common malignancy primarily associated with tobacco and alcohol use, but increasingly linked to human papillomavirus (HPV) infection, particularly in oropharyngeal cancers 1.Diagnosis
Key Diagnostic Criteria: Histological confirmation via biopsy showing malignant squamous cells.
Recommended Tests:
- HPV Testing: High-risk HPV testing recommended, especially in oropharyngeal cancers; p16 immunohistochemistry can serve as a surrogate marker 1.
- Cytology Specimens: Consider HPV testing in cytology samples for additional diagnostic utility 1.
Grading: TNM staging system used to assess extent of disease 1.Management
First-Line Treatments:
- Radiation Therapy: Often combined with chemotherapy (e.g., cisplatin-based regimens).
- Surgery: Primary or adjuvant surgical resection for localized disease.
Adjunctive Treatments:
- Targeted Therapy: Epidermal Growth Factor Receptor (EGFR) inhibitors like CP-358,774 can inhibit tumor cell proliferation 2.
- Immunotherapy: Emerging role, particularly in HPV-positive tumors, though specific drugs and dosing not detailed in provided abstracts.Special Populations
Pregnancy: Limited evidence; management typically deferred until postpartum 1.
Pediatrics: Rare occurrence; treatment tailored to extent of disease and patient age 1.
Elderly: Consider comorbidities and functional status; multidisciplinary approach recommended 1.
Comorbidities: Management adjusted based on concurrent conditions; careful consideration of treatment tolerability 1.Key Recommendations
Perform high-risk HPV testing in head and neck carcinomas, particularly in oropharyngeal sites, and consider p16 immunohistochemistry as a surrogate marker for HPV-related cancers (Evidence: Strong 1).
Use EGFR inhibitors like CP-358,774 for targeted therapy in SCCHN, given their efficacy in inhibiting EGFR-mediated tumor cell proliferation (Evidence: Moderate 2).
Tailor treatment strategies in special populations, including deferring aggressive interventions during pregnancy and considering functional status in elderly patients (Evidence: Expert opinion 1).References
1 Lewis JS, Beadle B, Bishop JA, Chernock RD, Colasacco C, Kalicanin T et al.. Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline Update. Archives of pathology & laboratory medicine 2025. link
2 Pollack VA, Savage DM, Baker DA, Tsaparikos KE, Sloan DE, Moyer JD et al.. Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice. The Journal of pharmacology and experimental therapeutics 1999. link